Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Cohort Study on Adjuvant Treatment of Coronary Heart Disease Angina Pectoris With Chinese Patent Medicine

NCT04022031 is registered in ClinicalTrials.gov with Tianjin University of Traditional Chinese Medicine as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04022031 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Cohort Study on Adjuvant Treatment of Coronary Heart Disease Angina Pectoris With Chinese Patent Medicine
Lead sponsor
Tianjin University of Traditional Chinese Medicine
Phase
Observational
Overall status
Unknown status
Start date
September 1, 2019
Completion date
September 1, 2022
Enrollment
12,400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerotic heart disease with angina nos